Minerva Surgical, Inc. Common Stock
UTRS
UTRS was delisted on the 28th of December, 2023.
25 hedge funds and large institutions have $103M invested in Minerva Surgical, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
69.55% more ownership
Funds ownership: 0% → 69.55% (+70%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$71.1M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$15.8M |
| 3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$14.6M |
| 4 |
VVM
Versant Venture Management
San Francisco,
California
|
+$11.9M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
+$8.46M |
Top Sellers
UTRS Hedge Fund Activity: Q4 2021 in Review
25 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Minerva Surgical, Inc. Common Stock (UTRS) for Q4 2021, worth a combined $103M.
Buyers outnumbered sellers: 25 funds opened new UTRS positions and 0 closed out — a net gain of 25 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $71.1M.
- 25 institutional investors held Minerva Surgical, Inc. Common Stock (UTRS) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $103M of Minerva Surgical, Inc. Common Stock stock for Q4 2021.
- 25 funds opened new Minerva Surgical, Inc. Common Stock positions in Q4 2021 and 0 closed out, a net change of +25 holders.
- The largest Minerva Surgical, Inc. Common Stock buyer in Q4 2021 was NEA Management Company, an estimated $71.1M added.
Based on aggregated 13F filings for Q4 2021.